Press Release Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets 9 hours ago
Press Release Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update Aug 19